These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27874856)

  • 1. In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.
    Latella MC; Di Salvo MT; Cocchiarella F; Benati D; Grisendi G; Comitato A; Marigo V; Recchia A
    Mol Ther Nucleic Acids; 2016 Nov; 5(11):e389. PubMed ID: 27874856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.
    Giannelli SG; Luoni M; Castoldi V; Massimino L; Cabassi T; Angeloni D; Demontis GC; Leocani L; Andreazzoli M; Broccoli V
    Hum Mol Genet; 2018 Mar; 27(5):761-779. PubMed ID: 29281027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
    Liu X; Jia R; Meng X; Li Y; Yang L
    Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 Gene Editing In Vitro and in Retinal Cells In Vivo.
    Benati D; Marigo V; Recchia A
    Methods Mol Biol; 2019; 1834():59-74. PubMed ID: 30324436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
    Du W; Li J; Tang X; Yu W; Zhao M
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.
    Li P; Kleinstiver BP; Leon MY; Prew MS; Navarro-Gomez D; Greenwald SH; Pierce EA; Joung JK; Liu Q
    CRISPR J; 2018 Feb; 1(1):55-64. PubMed ID: 31021187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice.
    Yan Z; Yao Y; Li L; Cai L; Zhang H; Zhang S; Xiao Q; Wang X; Zuo E; Xu C; Wu J; Yang H
    Mol Ther Nucleic Acids; 2023 Sep; 33():750-761. PubMed ID: 37621413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
    Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S
    Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
    Orlans HO; Barnard AR; Patrício MI; McClements ME; MacLaren RE
    Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific gene-editing approach for vision loss restoration in
    Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
    Elife; 2023 Jun; 12():. PubMed ID: 37272616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy in
    Wen RH; Stanar P; Tam B; Moritz OL
    Autophagy; 2019 Nov; 15(11):1970-1989. PubMed ID: 30975014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa.
    Shahin S; Xu H; Lu B; Mercado A; Jones MK; Bakondi B; Wang S
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
    Mitra RN; Zheng M; Weiss ER; Han Z
    Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa.
    Burnight ER; Wiley LA; Mullin NK; Adur MK; Lang MJ; Cranston CM; Jiao C; Russell SR; Sohn EH; Han IC; Ross JW; Stone EM; Mullins RF; Tucker BA
    CRISPR J; 2023 Dec; 6(6):502-513. PubMed ID: 38108516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
    Qin W; Wang H
    Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of mutant P23H rhodopsin in an RFP fusion knock-in mouse model of retinitis pigmentosa.
    Robichaux MA; Nguyen V; Chan F; Kailasam L; He F; Wilson JH; Wensel TG
    Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35275162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P23H opsin knock-in mice reveal a novel step in retinal rod disc morphogenesis.
    Sakami S; Kolesnikov AV; Kefalov VJ; Palczewski K
    Hum Mol Genet; 2014 Apr; 23(7):1723-41. PubMed ID: 24214395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic in vivo quantification of rod photoreceptor degeneration using fluorescent reporter mouse models of retinitis pigmentosa.
    Orlans HO; Barnard AR; MacLaren RE
    Exp Eye Res; 2020 Jan; 190():107895. PubMed ID: 31816293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
    Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
    Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.
    Luan XR; Chen XL; Tang YX; Zhang JY; Gao X; Ke HP; Lin ZY; Zhang XN
    Mol Ther Nucleic Acids; 2018 Sep; 12():220-228. PubMed ID: 30195761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.